How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales?
ABBV heads into Q1 earnings with Skyrizi and Rinvoq in focus as Humira declines, while growth from new indications and market share gains is under watch. [...]
AI Boom Aids LRCX's Systems Revenue Growth: Can the Momentum Continue?
Lam Research rides AI-driven chip demand as Systems revenue jumps 28%, with rising WFE spending and new tech adoption fueling near-term growth momentum. [...]
'Talking to AI feels easier than talking to a real person': 26% of Gen Z are already dating AI — and it’s not just about sex
A new survey shows AI is becoming a source of emotional and romantic connection for some people, even as many recognize it reflects deeper loneliness [...]
The OpenAI Safety Fellowship, announced on 6 April 2026, is a pilot programme for external researchers to conduct independent work on AI safety and alignment. It runs from September 2026 to February 2 [...]